From September 1, 2023 to November 30, 2023, the company has repurchased 281,900 shares, representing 0.31% for CAD 0.27 million. With this, the company has completed the repurchase of 976,394 shares, representing 1.08% for CAD 0.91 million under the buyback announced on November 30, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7 CAD | 0.00% | +1.45% | -15.66% |
1st Jan change | Capi. | |
---|---|---|
-15.66% | 46.04M | |
+11.11% | 223M | |
-3.09% | 200M | |
+22.67% | 160M | |
+21.30% | 110M | |
+300.00% | 121M | |
-57.00% | 90.83M | |
-28.57% | 121M | |
+71.19% | 95.96M | |
-15.38% | 73.56M |
- Stock Market
- Equities
- LOVE Stock
- News Cannara Biotech Inc.
- Tranche Update on Cannara Biotech Inc.'s Equity Buyback Plan announced on November 30, 2022.